Incidence, clinical classification and risk factors of cyclosporin A‐induced liver injury in allogeneic haematopoietic stem cell transplant recipients

Documenti analoghi

• Effects of routes, concentrations and genetic polymorphisms on posaconazole–tacrolimus interactions in allogeneic haematopoietic cell transplantation
  di: Masatomo Kuno, et al.
  Pubblicazione: (2025)
• Population pharmacokinetics and bioavailability of tacrolimus oral suspension in children with haematopoietic stem cell transplant
  di: Lucas Brstilo, et al.
  Pubblicazione: (2025)
• Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trials
  di: Krzysztof Kalwak, et al.
  Pubblicazione: (2024)
• Prediction of neutrophil nadir and recovery following paediatric haematopoietic cell transplantation with busulfan conditioning
  di: Beth Apsel Winger, et al.
  Pubblicazione: (2025)
• Recombinant zoster vaccine induces superior immunogenicity compared with live varicella vaccine in allogeneic haematopoietic stem cell transplantation recipients
  di: Takaaki Ono, et al.
  Pubblicazione: (2026)